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To the Editor,
The emergence of the novel coronavirus disease-19 (COVID-19) in
December 2019 resulted in a significant number of cases as reported by
the World Health Organization (WHO) and was subsequently declared
by the WHO as a pandemic on Mar 11, 2020. The review of the WHO
data reveals some perplexing facts.
There was a genetic variation of SARS-CoV-2, the etiologic agent of
COVID-19 [1]. In addition, there were three genomic variants, termed
A, B, and C, based on amino acid changes. COVID-19 variant A is the
ancestral type, and both A and C types are found in significant pro-
portions in Europe and America [2]. In the absence of a documented
difference in the virulence of these COVID-19 variants, it is challenging
to explain the wild differences in prevalence and mortality rates in the
different countries affected by COVID-19. Differences in the diagnostic
efforts, or differences in the definition or reporting cannot, in our
opinion, explain the wide variation of the data.
Climactic conditions have been postulated as a potential explana-
tion for heightened transmission of COVID-19 and the occurrence of
community outbreaks in countries with temperature of 5–11 °C and low
humidity resembles seasonal influenza [3]. However, other factors,
such as greater number of commercial or tourist travel might in-
dependently influence the spread of COVID-19.
Specifically, when we examined the reported data, we were struck
by the great variability of the number of confirmed cases per million.
According to the available data as of April 16, 2020, the number of
confirmed cases/million is 2732 in Italy, 207 in Korea, 909 in Iran, 982
in Bahrain, 3864 in Spain, 57 in China, 68 in Japan, and 168 in the
Fig. 1. Country-specific estimates of COVID-19 cases per million inhabitants (From https://www.worldometers.info/coronavirus/).
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Kingdom of Saudi Arabia (KSA) (Fig. 1).
The orders of magnitude difference between Italy (2732/MM) and
the KSA (168/MM) speak of an enormous difference in the propagation
of COVID-19. This gigantic gap is dwarfed by the three order of mag-
nitude difference between the KSA (168/MM) and the Italian epicenter
in the province of Bergamo (>3000/MM).
When we examined the mortality rates reported by various coun-
tries, the mortality again varies greatly. Italy is reporting the highest
mortality (13.1% on April 16, 2020), whereas, Iran (6.3%), China (4%),
Spain (10.4%), France (11.6%) and Korea (2.1%) described lower
mortality rates. At the bottom of the countries with low mortality are
Bahrain and Singapore (with 0.3–0.4% mortality). Are there plausible
explanations for the great variability in disease prevalence within the
different countries? Social habits (greetings customs, ease to touch
another person, kissing etc.) could possibly play a role, as could a
greater susceptibility of the population, the presence of “super-sprea-
ders” [4] or a delayed implementation of measures intended to stop the
spread of infectious disease such as social distancing and closure of
public areas. One study indicated that variation in prevalence could be
due to differences in transmission and migration rates [3]. What en-
abled China to contain the spread of the epidemic was most certainly
the coordinated effort of the central government to shut down Wuhan
on January 23rd, followed on January 24th by the shutdown of another
15 cities: since then the number of new cases began to go down. This
extremely successful endeavor is the result of draconian measures im-
plemented with military discipline, and thus this measure maybe dif-
ficult to implement in western countries.
Are there plausible explanations for the great variability in mor-
tality rate? There was a variation in the risk of death in a study from
China. -The estimates of the risk for death was 12% in the epicenter of
Wuhan and 1% in other, more mildly affected areas [5]. A higher
average age of the population, (particularly in Italy with a median age
of (47.4 years), accompanying higher percentage of comorbidities, most
likely play a significant role in death rates. In one study, older age and
higher Sequential Organ Failure Assessment (SOFA) score were asso-
ciated with increased mortality [6]. Sadly, in certain instances, it ap-
pears that the underlying cause of dramatically higher mortality, to this
date, was a drastic decrease in availability of critical resources. This
decrease in resources leads to a functional collapse of the healthcare
system and an overwhelmingly and unmanageable surge of people
needing assistance in the intensive care units.
In the absence of a single plausible explanation for the existence of
such dramatic disparities, we feel that home quarantine and isolation of
the vulnerable populations (such as the elderly and the frail) along with
the draconian measures being implemented in many countries are
justified in order to successfully contain and eventually overcome the
current pandemic due to COVID-19.
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1 Dr. Gino Fasoli, a semi-retired Primary Care physician, contracted COVID-19 and died on March 13, 2020.
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